← Evidence map

ArticleOncotarget2015

Mutant HRAS as novel target for MEK and mTOR inhibitors.

Michael K Kiessling et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

30 papers cite it

2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 26544513